Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSULET CORPORATION

(PODD)
  Report
Delayed Quote. Delayed Nasdaq - 12/02 04:00:01 pm
287.24 USD   +1.33%
11/25Insulet to Present at Nasdaq's 45th Investor Conference
AQ
11/24Insulet to Present at Nasdaq's 45th Investor Conference
BU
11/15INSIDER SELL : Insulet
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Sell: Insulet

10/04/2021 | 05:13pm EST


© MT Newswires 2021
All news about INSULET CORPORATION
11/25Insulet to Present at Nasdaq's 45th Investor Conference
AQ
11/24Insulet to Present at Nasdaq's 45th Investor Conference
BU
11/15INSIDER SELL : Insulet
MT
11/08Raymond James Adjusts Price Target on Insulet to $329 from $285, Keeps Outperform Ratin..
MT
11/08UBS Lifts Insulet's Price Target to $325 From $267 on Sales Estimates; Neutral Rating K..
MT
11/08Berenberg Bank Adjusts Insulet's Price Target to $295 From $277, Maintains Hold Rating
MT
11/05SVB Leerink Adjusts Price Target on Insulet to $350 from $300, Keeps Outperform Rating
MT
11/05INSULET CORP Management's Discussion and Analysis of Financial Condition and Results o..
AQ
11/04Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year - Form 8-K
PU
11/04Insulet Posts Q3 EPS Gain Short of Street View as Revenue Rises, Lifts Low End of 2021 ..
MT
More news
Analyst Recommendations on INSULET CORPORATION
More recommendations
Financials (USD)
Sales 2021 1 092 M - -
Net income 2021 15,6 M - -
Net Debt 2021 347 M - -
P/E ratio 2021 1 223x
Yield 2021 -
Capitalization 19 810 M 19 810 M -
EV / Sales 2021 18,5x
EV / Sales 2022 15,6x
Nbr of Employees 1 900
Free-Float 99,5%
Chart INSULET CORPORATION
Duration : Period :
Insulet Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSULET CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 287,24 $
Average target price 309,65 $
Spread / Average Target 7,80%
EPS Revisions
Managers and Directors
Shacey Petrovic President, Chief Executive Officer & Director
Wayde Dwight McMillan Chief Financial Officer, Treasurer & Executive VP
Timothy J. Scannell Independent Chairman
Trang Ly Senior Vice President & Medical Director
Charles Alpuche Chief Operations Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
INSULET CORPORATION12.37%19 549
ABBOTT LABORATORIES17.25%224 113
MEDTRONIC PLC-8.42%141 843
BECTON, DICKINSON AND COMPANY-3.42%68 640
HOYA CORPORATION24.39%59 332
DEXCOM, INC.51.53%53 147